Audit-first protocol models residual influence in interactions, suggesting a structured approach to information legacy.
This release provides Protocol-R v0.1 (Resonance Legacy Model), an audit-first protocol for residual influence, expressed as time-decaying effects after discrete interaction events, and used here as a structural metaphor for informational, cultural, and psychological legacy (NO OVERCLAIM). What this is An audit-first, copy-safe protocol for modelling and auditing residual influence after interactions. A Concept Lock for core objects, gate posture, and audit outcomes. Not a proof. Not a clinical claim. Not an ontological claim (no “entities” asserted). What this is NOT (NO OVERCLAIM) NOT a proof claim. NOT a clinical / treatment / patient-specific guidance document. NOT an ontological claim about “spirits” or “ghosts”. NOT a performance claim unless explicitly supported by artefacts/logs. Core objects (frozen in v0.1) Discrete interaction events indexed by k with event times t_k Residual influence kernel / decay controlled by alpha Influence channel / coupling terms A_k, C_ik Phase / alignment term phi (as defined in the paper) Audit posture Outputs are judged only under explicit PASS / FAIL / INCOMPLETE conditions. No post-hoc fitting: thresholds and interpretations must not be retrofitted after outcomes are known. Change control: any modification requires version bump + diff note. Separation note (anti-confusion) This protocol is not QRCF and does not assert physical “fields” or entities. It is a separate audit-first protocol for residual influence / legacy modelling as an auditable structure. Artefacts (this record) Main (PDF, Nature-style) Main (DOCX, Arial) INSTALL_ME (ASCII txt) INSTALL_ME (PDF) Governance Audit-first | NO OVERCLAIM | FACT-BASED Axis: Peace / Non-violence / Dignity Dual-use boundary: NO military / NO surveillance / NO coercion
No takes yet. Share an insight, caveat, or question.
Hisashi Suga (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: